GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 3, Pages 540
Publisher
MDPI AG
Online
2020-09-17
DOI
10.3390/vaccines8030540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
- (2019) Rene S. Hendriksen et al. Nature Communications
- Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
- (2019) Zoltán Kis et al. Biotechnology Journal
- Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
- (2019) Puthupparampil V. Scaria et al. npj Vaccines
- Glycoconjugate vaccines: current approaches towards faster vaccine design
- (2019) Francesca Micoli et al. Expert Review of Vaccines
- Setup of luminescence-based serum bactericidal assay against Salmonella Paratyphi A
- (2018) Francesca Necchi et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
- (2018) Francesca Micoli et al. MOLECULES
- IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates
- (2018) Anna E. Schager et al. mBio
- Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
- (2018) Francesca Micoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycoconjugate vaccines: Principles and mechanisms
- (2018) Rino Rappuoli Science Translational Medicine
- Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations
- (2018) Emma Ispasanie et al. Virulence
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Vaccine candidates for poor nations are going to waste
- (2018) David C. Kaslow et al. NATURE
- Antimicrobial resistance and the role of vaccines
- (2018) David E. Bloom et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Technologies to address antimicrobial resistance
- (2018) Stephen J. Baker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella
- (2017) G. De Benedetto et al. VACCINE
- A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)
- (2017) Ifeanyi Valentine Uche et al. PLoS Neglected Tropical Diseases
- A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
- (2017) Christina W. Obiero et al. Frontiers in Immunology
- Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
- (2017) Odile Launay et al. EBioMedicine
- Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
- (2016) Omar Rossi et al. Clinical and Vaccine Immunology
- An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children
- (2015) Richard I. Walker VACCINE
- Pathogenic E. coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells
- (2015) Maria Valeri et al. PLoS One
- Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
- (2015) Christiane Gerke et al. PLoS One
- Modulation of Endotoxicity ofShigellaGeneralized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications
- (2014) Omar Rossi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on Generalized Modules for Membrane Antigens (GMMA)
- (2014) Oliver Koeberling et al. VACCINE
- Vaccines against invasive Salmonella disease
- (2014) Calman A MacLennan et al. Human Vaccines & Immunotherapeutics
- SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains
- (2014) Barbara Nesta et al. PLoS Pathogens
- Invasive nontyphoidalSalmonelladisease in Africa: current status
- (2013) Calman A MacLennan et al. Expert Review of Anti-Infective Therapy
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+T Cell Immunity and Protection in Mice
- (2012) Kathrin Kastenmüller et al. INFECTION AND IMMUNITY
- Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa
- (2012) Nicholas A Feasey et al. LANCET
- Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial
- (2012) Siddhivinayak Hirve et al. VACCINE
- FdeC, a Novel Broadly Conserved Escherichia coli Adhesin Eliciting Protection against Urinary Tract Infections
- (2012) B. Nesta et al. mBio
- Evaluation of the Immunogenicity and Biological Activity of theCitrobacter freundiiVi-CRM197Conjugate as a Vaccine forSalmonella entericaSerovar Typhi
- (2011) Simona Rondini et al. Clinical and Vaccine Immunology
- Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi
- (2011) F. Micoli et al. VACCINE
- Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate
- (2010) Anna Kabanova et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started